Report Detail

Other Global Sickle Cell Disease Diagnosis and Treatment Market Growth (Status and Outlook) 2023-2029

  • RnM4500915
  • |
  • 05 January, 2023
  • |
  • Global
  • |
  • 110 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

newest research report, the “Sickle Cell Disease Diagnosis and Treatment Industry Forecast” looks at past sales and reviews total world Sickle Cell Disease Diagnosis and Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Sickle Cell Disease Diagnosis and Treatment sales for 2023 through 2029. With Sickle Cell Disease Diagnosis and Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sickle Cell Disease Diagnosis and Treatment industry.

This Insight Report provides a comprehensive analysis of the global Sickle Cell Disease Diagnosis and Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sickle Cell Disease Diagnosis and Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sickle Cell Disease Diagnosis and Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sickle Cell Disease Diagnosis and Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sickle Cell Disease Diagnosis and Treatment.

The global Sickle Cell Disease Diagnosis and Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Sickle Cell Disease Diagnosis and Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Sickle Cell Disease Diagnosis and Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Sickle Cell Disease Diagnosis and Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Sickle Cell Disease Diagnosis and Treatment players cover Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma and Bluebird Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Sickle Cell Disease Diagnosis and Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
Diagnosis
Treatment

Segmentation by application
Child
Adult

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size 2018-2029
    • 2.1.2 Sickle Cell Disease Diagnosis and Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 Sickle Cell Disease Diagnosis and Treatment Segment by Type
    • 2.2.1 Diagnosis
    • 2.2.2 Treatment
  • 2.3 Sickle Cell Disease Diagnosis and Treatment Market Size by Type
    • 2.3.1 Sickle Cell Disease Diagnosis and Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global Sickle Cell Disease Diagnosis and Treatment Market Size Market Share by Type (2018-2023)
  • 2.4 Sickle Cell Disease Diagnosis and Treatment Segment by Application
    • 2.4.1 Child
    • 2.4.2 Adult
  • 2.5 Sickle Cell Disease Diagnosis and Treatment Market Size by Application
    • 2.5.1 Sickle Cell Disease Diagnosis and Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global Sickle Cell Disease Diagnosis and Treatment Market Size Market Share by Application (2018-2023)

3 Sickle Cell Disease Diagnosis and Treatment Market Size by Player

  • 3.1 Sickle Cell Disease Diagnosis and Treatment Market Size Market Share by Players
    • 3.1.1 Global Sickle Cell Disease Diagnosis and Treatment Revenue by Players (2018-2023)
    • 3.1.2 Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Players (2018-2023)
  • 3.2 Global Sickle Cell Disease Diagnosis and Treatment Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Sickle Cell Disease Diagnosis and Treatment by Regions

  • 4.1 Sickle Cell Disease Diagnosis and Treatment Market Size by Regions (2018-2023)
  • 4.2 Americas Sickle Cell Disease Diagnosis and Treatment Market Size Growth (2018-2023)
  • 4.3 APAC Sickle Cell Disease Diagnosis and Treatment Market Size Growth (2018-2023)
  • 4.4 Europe Sickle Cell Disease Diagnosis and Treatment Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2018-2023)
  • 5.2 Americas Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2018-2023)
  • 5.3 Americas Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2018-2023)
  • 6.2 APAC Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2018-2023)
  • 6.3 APAC Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Sickle Cell Disease Diagnosis and Treatment by Country (2018-2023)
  • 7.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2018-2023)
  • 7.3 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment by Region (2018-2023)
  • 8.2 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Sickle Cell Disease Diagnosis and Treatment Market Forecast

  • 10.1 Global Sickle Cell Disease Diagnosis and Treatment Forecast by Regions (2024-2029)
    • 10.1.1 Global Sickle Cell Disease Diagnosis and Treatment Forecast by Regions (2024-2029)
    • 10.1.2 Americas Sickle Cell Disease Diagnosis and Treatment Forecast
    • 10.1.3 APAC Sickle Cell Disease Diagnosis and Treatment Forecast
    • 10.1.4 Europe Sickle Cell Disease Diagnosis and Treatment Forecast
    • 10.1.5 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Forecast
  • 10.2 Americas Sickle Cell Disease Diagnosis and Treatment Forecast by Country (2024-2029)
    • 10.2.1 United States Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.2.2 Canada Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.2.3 Mexico Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.2.4 Brazil Sickle Cell Disease Diagnosis and Treatment Market Forecast
  • 10.3 APAC Sickle Cell Disease Diagnosis and Treatment Forecast by Region (2024-2029)
    • 10.3.1 China Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.3.2 Japan Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.3.3 Korea Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.3.4 Southeast Asia Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.3.5 India Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.3.6 Australia Sickle Cell Disease Diagnosis and Treatment Market Forecast
  • 10.4 Europe Sickle Cell Disease Diagnosis and Treatment Forecast by Country (2024-2029)
    • 10.4.1 Germany Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.4.2 France Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.4.3 UK Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.4.4 Italy Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.4.5 Russia Sickle Cell Disease Diagnosis and Treatment Market Forecast
  • 10.5 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Forecast by Region (2024-2029)
    • 10.5.1 Egypt Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.5.2 South Africa Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.5.3 Israel Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.5.4 Turkey Sickle Cell Disease Diagnosis and Treatment Market Forecast
    • 10.5.5 GCC Countries Sickle Cell Disease Diagnosis and Treatment Market Forecast
  • 10.6 Global Sickle Cell Disease Diagnosis and Treatment Forecast by Type (2024-2029)
  • 10.7 Global Sickle Cell Disease Diagnosis and Treatment Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Emmaus Medical
    • 11.1.1 Emmaus Medical Company Information
    • 11.1.2 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.1.3 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Emmaus Medical Main Business Overview
    • 11.1.5 Emmaus Medical Latest Developments
  • 11.2 Addmedica
    • 11.2.1 Addmedica Company Information
    • 11.2.2 Addmedica Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.2.3 Addmedica Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 Addmedica Main Business Overview
    • 11.2.5 Addmedica Latest Developments
  • 11.3 Gamida Cell
    • 11.3.1 Gamida Cell Company Information
    • 11.3.2 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.3.3 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 Gamida Cell Main Business Overview
    • 11.3.5 Gamida Cell Latest Developments
  • 11.4 GlycoMimetics
    • 11.4.1 GlycoMimetics Company Information
    • 11.4.2 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.4.3 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 GlycoMimetics Main Business Overview
    • 11.4.5 GlycoMimetics Latest Developments
  • 11.5 Pfizer
    • 11.5.1 Pfizer Company Information
    • 11.5.2 Pfizer Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.5.3 Pfizer Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 Pfizer Main Business Overview
    • 11.5.5 Pfizer Latest Developments
  • 11.6 Novartis
    • 11.6.1 Novartis Company Information
    • 11.6.2 Novartis Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.6.3 Novartis Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 Novartis Main Business Overview
    • 11.6.5 Novartis Latest Developments
  • 11.7 Global Blood Therapeutics
    • 11.7.1 Global Blood Therapeutics Company Information
    • 11.7.2 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.7.3 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 Global Blood Therapeutics Main Business Overview
    • 11.7.5 Global Blood Therapeutics Latest Developments
  • 11.8 Micelle BioPharma
    • 11.8.1 Micelle BioPharma Company Information
    • 11.8.2 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.8.3 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 Micelle BioPharma Main Business Overview
    • 11.8.5 Micelle BioPharma Latest Developments
  • 11.9 Bluebird Bio
    • 11.9.1 Bluebird Bio Company Information
    • 11.9.2 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.9.3 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.9.4 Bluebird Bio Main Business Overview
    • 11.9.5 Bluebird Bio Latest Developments
  • 11.10 Prolong Pharmaceuticals
    • 11.10.1 Prolong Pharmaceuticals Company Information
    • 11.10.2 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.10.3 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.10.4 Prolong Pharmaceuticals Main Business Overview
    • 11.10.5 Prolong Pharmaceuticals Latest Developments
  • 11.11 Modus Therapeutics
    • 11.11.1 Modus Therapeutics Company Information
    • 11.11.2 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.11.3 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.11.4 Modus Therapeutics Main Business Overview
    • 11.11.5 Modus Therapeutics Latest Developments
  • 11.12 Sangamo Biosciences
    • 11.12.1 Sangamo Biosciences Company Information
    • 11.12.2 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.12.3 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.12.4 Sangamo Biosciences Main Business Overview
    • 11.12.5 Sangamo Biosciences Latest Developments
  • 11.13 Bioverativ
    • 11.13.1 Bioverativ Company Information
    • 11.13.2 Bioverativ Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.13.3 Bioverativ Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.13.4 Bioverativ Main Business Overview
    • 11.13.5 Bioverativ Latest Developments
  • 11.14 Imara
    • 11.14.1 Imara Company Information
    • 11.14.2 Imara Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.14.3 Imara Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.14.4 Imara Main Business Overview
    • 11.14.5 Imara Latest Developments
  • 11.15 Ironwood Pharmaceuticals
    • 11.15.1 Ironwood Pharmaceuticals Company Information
    • 11.15.2 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product Offered
    • 11.15.3 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 11.15.4 Ironwood Pharmaceuticals Main Business Overview
    • 11.15.5 Ironwood Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Sickle Cell Disease Diagnosis and Treatment. Industry analysis & Market Report on Sickle Cell Disease Diagnosis and Treatment is a syndicated market report, published as Global Sickle Cell Disease Diagnosis and Treatment Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Sickle Cell Disease Diagnosis and Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,898.72
5,797.44
3,381.84
6,763.68
553,721.40
1,107,442.80
305,134.20
610,268.40
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report